Literature DB >> 31706476

The Spectrum of Idiopathic Ventricular Fibrillation and J-Wave Syndromes: Novel Mapping Insights.

Michel Haïssaguerre1, Wee Nademanee2, Mélèze Hocini3, Josselin Duchateau4, Clementine André4, Thomas Lavergne5, Masa Takigawa6, Frederic Sacher4, Nicolas Derval4, Thomas Pambrun4, Pierre Jais4, Rick Walton5, Mark Potse5, Ed Vigmond5, Remi Dubois5, Olivier Bernus7.   

Abstract

Idiopathic ventricular fibrillation and J-wave syndromes are causes of sudden cardiac death (SCD) without any identified structural cardiac disease after extensive investigations. Recent data show that high-density electrophysiological mapping may ultimately offer diagnoses of subclinical diseases in most patients including those termed "unexplained" SCD. Three major conditions can underlie the occurrence of SCD: (1) localized depolarization abnormalities (due to microstructural myocardial alteration), (2) Purkinje abnormalities manifesting as triggering ectopy and inducible reentry; or (3) repolarization heterogeneities. Each condition may result from a spectrum of pathophysiologic processes with implications for individual therapy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early repolarization syndromes; J-wave syndromes; Purkinje system; Sudden cardiac death; Ventricular fibrillation

Year:  2019        PMID: 31706476     DOI: 10.1016/j.ccep.2019.08.011

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  2 in total

1.  Association Between Temporal Changes in Early Repolarization Pattern With Long-Term Cardiovascular Outcome: A Population-Based Cohort Study.

Authors:  Li-Juan Liu; Na Tang; Wen-Tao Bi; Ming Zhang; Xue-Qiong Deng; Yun-Jiu Cheng
Journal:  J Am Heart Assoc       Date:  2022-03-09       Impact factor: 6.106

Review 2.  Developing a Mechanistic Approach to Sudden Death Prevention in Mitral Valve Prolapse.

Authors:  Brian P Kelley; Abdul Mateen Chaudry; Faisal F Syed
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.